Celadon Partners SPV 24
CIK: 0002060465
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SNTI
Senti Biosciences, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About Celadon Partners SPV 24
Celadon Partners SPV 24 (SEC CIK 0002060465) files insider reports with the SEC as 10% Owner of Senti Biosciences, Inc. (SNTI).
Signal8 holds 2 ownership filings by Celadon Partners SPV 24 (1 Form 3, 1 Form 4), filed between Mar 13, 2025 and Mar 14, 2025. Those filings report 1 transaction, the latest on Mar 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Celadon Partners SPV 24's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Celadon Partners SPV 24
- Mar 10, 2025: Conversion of SNTI shares (Form 4, code C).
Other insiders filing for Senti Biosciences, Inc. (SNTI)
- Rajangam Kanya, Pres. & Chief Med. & Dev. Off.
- Lu Timothy K, CEO
- Baum Bryan Daniel, Director
- Collins James J., Director
- Hsiung Feng, Director
- Schulz Fran, Director